Icon
+91 94997 68112
Login Register

DIFICID - (200 mg; Tablet, Oral)

FIDAXOMICIN CUBIST (Merck)
200 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
 None
DIFICID is a macrolide antibacterial drug indicated in adults ( ≥ 18 years of age) for treatment of Clostridium difficile-associated diarrhea (CDAD).
Yes
******* ** *** ***** ** **** **** ** **** ******* '*** (***** **, ****), '*** (***** **, ****), '***(**** **, ****), '*** (**** **, ****), '*** (**** **, ****) *** *** ************ ********* ** ***** *** ******. ** ****** **** **** ******* ****** ** ***** ****. ***** ****** ** *********** ****** ** *** ****.
DIFICID Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ********* ***** *, **** ******* ******** ******* *** **** (***** ******) *** *** ****
  1. **** **, **** : ******* ******* ***** *** ****** ***** *** **** ** *** ******* **** ******* '*** (***** **, ****), '*** (***** **, ****), '***(**** **, ****), '*** (**** **, ****), '*** (**** **, ****).
  2. *** **, **** : ***** *** ****** ***** * **** ******* ******* ** ******** ***** ** ** *** ******** ***** ** ******* ********.
  3. *** *, **** : ***** *** ****** ******* **** ******* ** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.